Augmedix, Inc. announced on October 5, 2021, the board of directors of company appointed Jason Krikorian to the audit committee of the board of directors, replacing Emmanuel Krakaris on the audit committee. As a result of Mr. Krikorian’s appointment to the audit committee, the Company has a fully independent audit committee under Rule 10A-3(b)(1) of the Exchange Act and the Nasdaq Stock Market’s corporate governance rules.